These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16353122)

  • 1. Vaccines and immunotherapy for staphylococcal infections.
    Patti JM
    Int J Artif Organs; 2005 Nov; 28(11):1157-62. PubMed ID: 16353122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MSCRAMM--targeted vaccines and immunotherapy for staphylococcal infection.
    Rivas JM; Speziale P; Patti JM; Höök M
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):223-7. PubMed ID: 15603256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapeutics for nosocomial infections.
    Patti JM
    Expert Opin Investig Drugs; 2004 Jun; 13(6):673-9. PubMed ID: 15174953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted immunotherapy for staphylococcal infections : focus on anti-MSCRAMM antibodies.
    Otto M
    BioDrugs; 2008; 22(1):27-36. PubMed ID: 18215088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcus biofilm components as targets for vaccines and drugs.
    Visai L; Arciola CR; Pietrocola G; Rindi S; Olivero P; Speziale P
    Int J Artif Organs; 2007 Sep; 30(9):813-9. PubMed ID: 17918127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapeutic strategies to combat staphylococcal infections.
    Ohlsen K; Lorenz U
    Int J Med Microbiol; 2010 Aug; 300(6):402-10. PubMed ID: 20547101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoprophylaxis and immunotherapy of Staphylococcus epidermidis infections: challenges and prospects.
    Van Mellaert L; Shahrooei M; Hofmans D; Eldere JV
    Expert Rev Vaccines; 2012 Mar; 11(3):319-34. PubMed ID: 22380824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcal vaccines and immunotherapy: to dream the impossible dream?
    Projan SJ; Nesin M; Dunman PM
    Curr Opin Pharmacol; 2006 Oct; 6(5):473-9. PubMed ID: 16870507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on DNA vaccines. Targeting staphylococcal adhesins to prevent implant infections.
    Arciola CR; Speziale P; Montanaro L
    Int J Artif Organs; 2009 Sep; 32(9):635-41. PubMed ID: 19882551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role and importance of immunotherapy in treating the infectious complications of burn patients].
    Panchenkov NR; Murazian RI
    Probl Gematol Pereliv Krovi; 1982 Feb; 27(2):46-8. PubMed ID: 7063469
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complex therapy of patients with staphylococcal sepsis].
    Proskurov VA
    Vrach Delo; 1974 Dec; (12):124-7. PubMed ID: 4446517
    [No Abstract]   [Full Text] [Related]  

  • 12. Methicillin-resistant Staphylococcus aureus: an update.
    Durai R; Ng PC; Hoque H
    AORN J; 2010 May; 91(5):599-606; quiz 607-9. PubMed ID: 20451002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternatives to antibiotics in an era of difficult-to-treat resistance: new insights.
    Rello J; Parisella FR; Perez A
    Expert Rev Clin Pharmacol; 2019 Jul; 12(7):635-642. PubMed ID: 31092053
    [No Abstract]   [Full Text] [Related]  

  • 14. Status update: hospital-acquired and community-acquired methicillin-resistant Staphylococcus aureus.
    Elston DM
    Cutis; 2007 Jun; 79(6 Suppl):37-42. PubMed ID: 17649856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Staphylococcus aureus immunotherapy: current status and prospects.
    García-Lara J; Foster SJ
    Curr Opin Pharmacol; 2009 Oct; 9(5):552-7. PubMed ID: 19733119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli and Staphylococcus aureus: leading bacterial pathogens of healthcare associated infections and bacteremia in older-age populations.
    Poolman JT; Anderson AS
    Expert Rev Vaccines; 2018 Jul; 17(7):607-618. PubMed ID: 29902092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines.
    Broughan J; Anderson R; Anderson AS
    Expert Rev Vaccines; 2011 May; 10(5):695-708. PubMed ID: 21604989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of various programs of immunocorrective therapy in chronic infectious-inflammatory diseases].
    Gordienko SM; Lozovoĭ VP; Avdiunicheva OE; Kozlov VA
    Ter Arkh; 1986; 58(4):86-9. PubMed ID: 3715763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapeutic approaches against Staphylococcus aureus.
    Verkaik NJ; van Wamel WJ; van Belkum A
    Immunotherapy; 2011 Sep; 3(9):1063-73. PubMed ID: 21913829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The problems, diagnosis and treatment of infection by Staphylococcus aureus.
    Williams RF
    Scott Med J; 1979 Jan; 24(1):53-8. PubMed ID: 493932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.